REVITOPE ONCOLOGY Trademark

Trademark Overview

On Wednesday, December 30, 2020, a trademark application was filed for REVITOPE ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the REVITOPE ONCOLOGY trademark a serial number of 90430529. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Friday, June 14, 2024. This trademark is owned by Revitope Oncology, Inc.. The REVITOPE ONCOLOGY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, immunotherapies for the treatment of cancer and oncological conditions; oncological preparations, namely, pharmaceutical products for the detection, prevention, and treatment of cancer; anti-cancer preparations; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the prevention and treatment of cancer and oncological conditions
revitope oncology

General Information

Serial Number90430529
Word MarkREVITOPE ONCOLOGY
Filing DateWednesday, December 30, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateFriday, June 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 19, 2021

Trademark Statements

Goods and ServicesPharmaceuticals, namely, immunotherapies for the treatment of cancer and oncological conditions; oncological preparations, namely, pharmaceutical products for the detection, prevention, and treatment of cancer; anti-cancer preparations; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the prevention and treatment of cancer and oncological conditions
NOT AVAILABLE"ONCOLOGY"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 24, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRevitope Oncology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameRevitope Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Saturday, January 2, 2021NEW APPLICATION ENTERED
Wednesday, March 24, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, June 20, 2021ASSIGNED TO EXAMINER
Sunday, July 11, 2021NON-FINAL ACTION WRITTEN
Sunday, July 11, 2021NON-FINAL ACTION E-MAILED
Sunday, July 11, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 14, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 14, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, September 14, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 14, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, September 14, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 29, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 19, 2021PUBLISHED FOR OPPOSITION
Tuesday, October 19, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 14, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 14, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, June 14, 2022SOU EXTENSION 1 FILED
Tuesday, June 14, 2022SOU EXTENSION 1 GRANTED
Thursday, June 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 14, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 14, 2022SOU EXTENSION 2 FILED
Wednesday, December 14, 2022SOU EXTENSION 2 GRANTED
Friday, December 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 14, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, June 14, 2023SOU EXTENSION 3 FILED
Wednesday, June 14, 2023SOU EXTENSION 3 GRANTED
Friday, June 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 14, 2023SOU TEAS EXTENSION RECEIVED
Thursday, December 14, 2023SOU EXTENSION 4 FILED
Thursday, December 14, 2023SOU EXTENSION 4 GRANTED
Saturday, December 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 14, 2024SOU TEAS EXTENSION RECEIVED
Friday, June 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 14, 2024SOU EXTENSION 5 GRANTED
Friday, June 14, 2024SOU EXTENSION 5 FILED

Related Keywords

oncology revitope cancer oncological treatment preparations conditions prevention pharmaceutical products namely biological